I think we took a round or 3 from our own gun - needlessly so - my expectations are congruent with Dave's - I believe 4Q will have some key developmental milestone accomplishments as outlined in the SEC filing - by my thoughts are on January and the BioMed conference in 2015 - I believe the share price is looking for a bottom and will be much improved by then. But I also believe the RS will be done at a higher ratio / multiple than I'd be comfortable with as well. At sometime in the 4Q, well start to rise again into mid January where I expect tobe between $0.15 and .$0.20